0001209191-18-042137.txt : 20180710
0001209191-18-042137.hdr.sgml : 20180710
20180710161154
ACCESSION NUMBER: 0001209191-18-042137
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180706
FILED AS OF DATE: 20180710
DATE AS OF CHANGE: 20180710
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kirson Eilon D.
CENTRAL INDEX KEY: 0001654356
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37565
FILM NUMBER: 18947086
MAIL ADDRESS:
STREET 1: TOPAZ BUILDING, MATAN CENTER
CITY: HAIFA
STATE: L3
ZIP: 31905
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NovoCure Ltd
CENTRAL INDEX KEY: 0001645113
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
BUSINESS PHONE: 44 (0)15 3475 6700
MAIL ADDRESS:
STREET 1: NO. 4 THE FORUM
STREET 2: GRENVILLE STREET
CITY: ST. HELIER
STATE: Y9
ZIP: JE2 4UF
FORMER COMPANY:
FORMER CONFORMED NAME: Novocure Ltd
DATE OF NAME CHANGE: 20150615
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-07-06
0
0001645113
NovoCure Ltd
NVCR
0001654356
Kirson Eilon D.
C/O NOVOCURE INC.,
VALLEY STREAM PARKWAY, SUITE 300
MALVERN
PA
19355
0
1
0
0
Chief Science Officer
Ordinary Shares
2018-07-06
4
A
0
1231
17.255
A
109063
D
The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of January 1, 2018 through June 30, 2018. This transaction is also exempt under Rule 16b-3(c).
In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on January 2, 2018.
By: /s/ Kimberly Burke, Attorney in fact for Eilon D. Kirson
2018-07-10